IGF-1 LR3 1

Reconstitution Required: Bacteriostatic Water needed for research peptide preparation (not for human use)

IGF-1 LR3 (Insulin-Like Growth Factor-1 Long R3) is a modified peptide analog of insulin-like growth factor-1 (IGF-1) that has been discussed in scientific literature for its interaction with IGF receptor pathways and cellular growth signaling mechanisms. It is utilized in controlled laboratory research environments as a model compound for studying cell proliferation pathways, protein synthesis–associated signaling, and intracellular communication systems.

In research settings, IGF-1 LR3 has been studied in connection with cellular growth and differentiation models, skeletal muscle–associated signaling frameworks, and metabolic pathway research under in-vitro and analytical conditions. Research interest centers on receptor binding dynamics, signal transduction behavior, and gene expression–associated pathways, rather than physiological, performance, or clinical outcomes.

Because of its role within IGF signaling research, IGF-1 LR3 is commonly examined in muscle cell signaling models, tissue development research frameworks, and nutrient-partitioning pathway studies, where investigators explore how growth factor signaling influences cellular behavior at the molecular level. These investigations focus on mechanistic understanding and pathway modeling, not muscle development, fat reduction, recovery enhancement, or clinical effects.

Any references to growth signaling, muscle-associated pathways, metabolic processes, or cellular development are provided solely for educational and laboratory context and do not imply therapeutic, physiological, performance-enhancing, or clinical outcomes.

Theramedix IGF-1 LR3 is produced to strict research-grade purity and handling standards for biochemical and molecular investigation only.

This material is provided exclusively for laboratory research, analytical study, and in-vitro investigation.
Not for human or veterinary use. For research use only.